Two of the biggest names in the super investor community, Radhakishan Damani and Late Rakesh Jhunjhunwala have shown strong ...

Dr. Raza Bokhari, Exec Chairman & CEO, Interviewed by Bloomberg Open Interest Anchor Matt Miller PHILADELPHIA, PA / ...

ABU DHABI, 25th February, 2026 (WAM) -- NYU Abu Dhabi and RTW Investments, LP (“RTW”) Wednesday announced a strategic collaboration to advance executive education, thought leadership, and cross-sector ...

Tether stablecoin payments get a boost as Tether invests in Whop, enhancing user transactions and expanding to new markets.

ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...

GenEdit is sailing toward the clinic with a new name and fresh funding.  | GenEdit is sailing toward the clinic with a new name and fresh funding. Rebranded as BreezeBio, the biotech has raised $60 ...

Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations.

Our fourth annual, two-day international event gathers top executives across commercial real estate and life sciences to dive into biotech growth, facilities of the future, innovative lab development, ...

From the National Logistics Policy (NLP) perspective, this evolution is not an abstract narrative about innovation rankings ...

Vir Biotechnology (VIR) is experiencing a surge of +58% pre-market due to a significant strategic partnership with Astellas concerning its prostate cancer ...

Q4 2025 earnings call highlights Astellas deal, VIR-5500 Phase I data, runway to 2028, and pipeline outlook—read now.